Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene
Open Access
- 23 July 2007
- journal article
- Published by Springer Nature in International Seminars in Surgical Oncology
- Vol. 4 (1) , 18
- https://doi.org/10.1186/1477-7800-4-18
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancerThe Breast, 2006
- Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancerInternational Journal of Cancer, 2005
- Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3Maturitas, 2005
- Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.2003
- Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.2003
- The GH–IGF-I axis and breast cancerTrends in Endocrinology & Metabolism, 2003
- Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancerBritish Journal of Cancer, 2001
- IGF status is altered by tamoxifen in patients with breast cancerMolecular Pathology, 2001
- Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesisJournal of Cellular Physiology, 2000
- Regulation of insulin-like growth factors by antiestrogenBreast Cancer Research and Treatment, 1994